IBB News and Press, iShares Biotechnology ETF From 07/09/23

2023-07-09 12:00:00 ET Despite a disappointing start to 2023, the healthcare sector has several promising industries waiting to outperform this year, Goldman Sachs said in a recent report after the bank concluded its annual healthcare conference in Dana Point, California, last month. Th...

2023-07-01 04:59:34 ET Summary Artificial Intelligence stands to revolutionize drug discovery and manufacturing in the biotech industry, promising faster, cost-effective processes, which could greatly benefit biotech investors. The SPDR S&P Biotech ETF, an equal-weighted fund ...

2023-06-19 05:16:46 ET Summary Pharma/biotechnology and healthcare providers are slightly undervalued relative to 11-year averages. Healthcare equipment is the most overvalued subsector. Fast facts on PBE, a genomics ETF. 10 healthcare stocks cheaper than their peers in Ju...

2023-06-15 17:51:43 ET Summary Biotech stocks have been largely out of relative favor in 2023. Amid possible market mean reversion and seasonal tailwinds, IBB's low P/E is a positive attribute. But poor absolute price action and relative performance weakness lead me to reitera...

2023-06-11 05:24:29 ET Summary The US private domestic sector balance increased by $130bn in May 2023, a positive result driven by a $246bn injection of funds from the federal government. Bank credit creation retraction continued for the fifth consecutive month, signaling a potent...

2023-06-09 07:36:00 ET Summary Healthcare companies are beginning to explore how artificial intelligence might unlock efficiencies for patients and medical systems. Companies that put cash to work by investing in innovation are signaling efforts to secure consistent long-term prof...

2023-06-09 02:00:00 ET Summary Recent clinical trial success for the second significant, disease-modifying drug to treat Alzheimer’s is a critical milestone and a positive sign for the future of neuroscience. Technological advancements, particularly artificial intelligence ...

2023-06-08 23:17:09 ET Summary The Health Care Select Sector SPDR ETF and the Vanguard Health Care ETF are the two most popular Health Care ETFs, with a combined $57 billion in assets under management. Both ETFs have a 0.10% expense ratio, a five-year beta around 0.70, and trade a...

2023-06-08 01:12:59 ET iShares Nasdaq Biotechnology ETF ( NASDAQ: IBB ) - $0.0062 . 30-Day SEC Yield of 0.19% as of April. 30. Payable Jun 13; for shareholders of record Jun 08; ex-div Jun 07. For further details see: iShares Nasdaq Biotechnology ETF declares...

2023-06-03 20:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...